Posted by Michael Wonder on 13 Jun 2019
TLV publishes first joint report within the FINOSE co-operation
11 June 2019 - FINOSE is a collaboration between the HTA authorities, the pharmaceutical company Fimea (Finland), the Norwegian Medicines Agency, NoMA (Norway) and TLV (Sweden).
The collaboration means that the authorities in project form make joint evaluations of drugs, both with regard to relative effect and health economy.
The first report is for enzalatamide (Xtandi) and the report has been published in English.
